Govt issues updated clinical guidance for management of COVID-19 patients

The guidelines issued by AIIMS, ICMR-COVID-19 National Task Force and the Joint Monitoring Group (DGHS) under the ministry stated that tocilizumab (a drug that modifies the immune system or its functioning) may be considered in patients with significantly raised inflammatory markers and not improving despite use of steroids with there being no active bacterial/fungal/tubercular infection.

Source: The Economic Times - April 23, 2021 Category: Consumer Health News Source Type: news